Alpha 1 Antitrypsin Deficiency News and Research

RSS
Drug used to treat schizophrenia, dementia has potential for treating liver disease

Drug used to treat schizophrenia, dementia has potential for treating liver disease

UMMS researchers commissioned by Alpha-1 Project to develop PiZ antibody

UMMS researchers commissioned by Alpha-1 Project to develop PiZ antibody

IQWiG publishes new clinical practice guidelines for treating people with COPD

IQWiG publishes new clinical practice guidelines for treating people with COPD

Polyphor, Roche agree to develop and commercialize antibiotic for bacterial infections

Polyphor, Roche agree to develop and commercialize antibiotic for bacterial infections

New smartphone app for patients with hemophilia and related bleeding disorders

New smartphone app for patients with hemophilia and related bleeding disorders

A1-PI treatment slows progression of emphysema in patients with AATD

A1-PI treatment slows progression of emphysema in patients with AATD

Scientists identify new mutation in a gene that causes Alpha-1 Antitrypsin Deficiency

Scientists identify new mutation in a gene that causes Alpha-1 Antitrypsin Deficiency

ALN RNAi therapeutic program represents novel approach for treatment of AAT deficiency

ALN RNAi therapeutic program represents novel approach for treatment of AAT deficiency

Oxidative stress occurs in genetic models of alpha-1-antitrypsin deficiency

Oxidative stress occurs in genetic models of alpha-1-antitrypsin deficiency

SLU professor to investigate natural history and progression of Alpha-1 Antitrypsin Deficiency

SLU professor to investigate natural history and progression of Alpha-1 Antitrypsin Deficiency

GSK, University of Cambridge aim to discover and develop new medicines for liver disease

GSK, University of Cambridge aim to discover and develop new medicines for liver disease

COPDF announces expansion of Bronchiectasis Research Registry

COPDF announces expansion of Bronchiectasis Research Registry

RCSI study: Alpha-1 antitrypsin deficiency more prevalent in Ireland

RCSI study: Alpha-1 antitrypsin deficiency more prevalent in Ireland

Nature publishes Sangamo's gene correction strategy for A1AT deficiency

Nature publishes Sangamo's gene correction strategy for A1AT deficiency

Isis designates ISIS-AATRx candidate in collaboration with GSK

Isis designates ISIS-AATRx candidate in collaboration with GSK

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

PPTA applauds introduction of 'Preserving Access to Orphan Drugs Act'

PPTA applauds introduction of 'Preserving Access to Orphan Drugs Act'

Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

PPTA offers new DVD on plasma donation

PPTA offers new DVD on plasma donation

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency